EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY 4.0

Clinical outcomes of CyberKnife stereotactic radiotherapy for localized prostate cancer: comparison of 35 Gy in 5 fractions and 36 Gy in 4 fractions

Jiyoon Lim iD, Yoon Y Jo, Sumin Lee iD, Yeon J Kim iD

Journal of Radiation Research · 26.05.2026 · 67 (3) · 402-411

DOI: 10.1093/jrr/rrag017 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Journal of Radiation Research, online erschienen am 14.04.2026. Verfasst von Jiyoon Lim und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Asan Medical Center, University of Ulsan College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul 05505, South K…. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Radiosurgery, Dose Fractionation, Radiation. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National IT Industry Promotion Agency and the Gangwon Information & Culture Industry Promotion Agency, Ministry of Science and ICT, Data-based Magnetic Modulated Radiation Therapy: Commercialization and Validation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This retrospective study evaluated the clinical outcomes of two CyberKnife (CK) stereotactic body radiation therapy (SBRT) regimens in patients with localized prostate cancer (LPC). A total of 249 patients were treated, with 123 receiving 35 Gy in 5 fractions and 126 receiving 36 Gy in 4 fractions, with a median follow-up of 50 months. The primary endpoint was the incidence of grade ≥2 genitourinary (GU) and gastrointestinal (GI) toxicities, assessed using CTCAE Version 5.0. Secondary endpoints included 3-year biochemical recurrence-free survival (BCRFS), locoregional recurrence-free survival (LRRFS) and distant metastasis-free survival (DMFS). To address baseline imbalances between groups, inverse probability of treatment weighting (IPTW) was applied. Acute grade 2 GU toxicities occurred in 19 patients (7.6%) and chronic grade 2 in 15 patients (6.0%). Acute and chronic grade 2 GI toxicities were rare, occurring in 3 (1.2%) and 2 (0.8%) patients, respectively. There were no significant differences in cumulative GU or GI toxicity rates between fractionation regimens either before or after IPTW adjustment. After IPTW, the 3-year BCRFS was 96.5% in the 5-fraction group and 96.8% in the 4-fraction groups (P = 0.571). The 3-year LRRFS rates were similarly favorable (99.2% vs. 100%). The 3-year DMFS was 100% in the 5-fraction group and 97.5% in the 4-fraction group (P = 0.058). Overall, CK-SBRT using 36 Gy in 4 fractions was well tolerated, with low rates of treatment-related toxicity and no statistically significant differences in oncologic outcomes between regimens. Longer follow-up is required to determine the long-term efficacy of this dose-escalation strategy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic NeoplasmsRadiosurgeryDose Fractionation, RadiationHumansMaleTreatment OutcomeAgedAged, 80 and overMiddle AgedRetrospective StudiesDisease-Free Survival

Stichwörter der Autor:innen

CyberKnifedose escalationprostate cancerstereotactic body radiation therapytoxicity

Autor:innen und Institutionen

  • Department of Radiation Oncology, Asan Medical Center, University of Ulsan College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul 05505, South Korea.
  • Department of Radiation Oncology, Yeungnam University Medical Center, 170 Hyeonchung-ro, Nam-gu, Daegu 42415, South Korea.
  • Department of Radiation Oncology, Kangwon National University Hospital, 156 Baengnyeong-ro, Chuncheon-si, Gangwon-do 24289, South Korea.

ORCID-Profile: Jiyoon Lim, Sumin Lee, Yeon J Kim

Förderung

  • National IT Industry Promotion Agency and the Gangwon Information & Culture Industry Promotion Agency
  • Ministry of Science and ICT
  • Data-based Magnetic Modulated Radiation Therapy: Commercialization and Validation

Zitieren

APA

Lim, J., Jo, Y. Y., Lee, S., & Kim, Y. J. (2026). Clinical outcomes of CyberKnife stereotactic radiotherapy for localized prostate cancer: comparison of 35 Gy in 5 fractions and 36 Gy in 4 fractions. Journal of Radiation Research, 67(3), 402-411. https://doi.org/10.1093/jrr/rrag017

Vancouver

Lim J, Jo YY, Lee S, Kim YJ. Clinical outcomes of CyberKnife stereotactic radiotherapy for localized prostate cancer: comparison of 35 Gy in 5 fractions and 36 Gy in 4 fractions. Journal of Radiation Research. 2026;67(3):402-411. doi:10.1093/jrr/rrag017

BibTeX
@article{Lim2026,
  author = {Lim, Jiyoon and Jo, Yoon Y and Lee, Sumin and Kim, Yeon J},
  title = {Clinical outcomes of CyberKnife stereotactic radiotherapy for localized prostate cancer: comparison of 35 Gy in 5 fractions and 36 Gy in 4 fractions},
  journal = {Journal of Radiation Research},
  year = {2026},
  volume = {67},
  number = {3},
  pages = {402--411},
  doi = {10.1093/jrr/rrag017}
}
Kostenlos starten →